The actress opened up to PEOPLE about her “miraculous” weight loss ...

GLP-1 medications are approved for several conditions, including Type 2 diabetes, obesity, cardiovascular disease, chronic kidney disease, liver disease and sleep apnea. Among GLP-1 drugs approved for ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

The rise of weight-loss drugs such as Ozempic and Wegovy has been nothing short of meteoric, with millions turning to the injections to shed pounds and improve their health. But beneath the dramatic ...

While the medications may be pricey, a multi-year study by Aon found consistent use correlates with lower medical cost growth ...

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

GLP-1s can work wonders for weight loss. But what happens when you stop taking them?

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been ...